Skip to main content

Table 16 The cost-effectiveness analysis in the 12-month intervention period (the reversion rate)

From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

Group

C (yuan)

E (%)

C/E

ΔC/ΔE

The treatment group

22967057.6

41.8

549451.1

 

The control group

20425193.3

27.8

734719.2

181561.7